相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-Preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: a Rabbit Ocular Surface Study
Hong Liang et al.
ADVANCES IN THERAPY (2011)
In Vitro Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination
Francoise Brignole-Baudouin et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial
Arthur Shedden et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Ocular Surface Tolerability of Prostaglandin Analogs in Patients with Glaucoma or Ocular Hypertension
Jess T. Whitson et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
In Vitro Toxicity of Topical Ocular Prostaglandin Analogs and Preservatives on Corneal Epithelial Cells
Malik Y. Kahook et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
The Effect of Lubricating Eye Drop Containing Hydroxypropyl Guar on Perimetry Results of Patients with Glaucoma and Trachomatous Dry Eye
Mustafa Guzey et al.
OPHTHALMOLOGICA (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Occludin gene expression as an early in vitro sign for mild eye irritation assessment
Marisa Meloni et al.
TOXICOLOGY IN VITRO (2010)
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
Jordana K. Schmier et al.
CLINICAL OPHTHALMOLOGY (2010)
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
Gregory Katz et al.
CLINICAL OPHTHALMOLOGY (2010)
Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
Masahiko Ayaki et al.
CLINICAL OPHTHALMOLOGY (2010)
A randomized clinical comparison of OPTI-FREE EXPRESS and ReNu MultiPLUS multipurpose lens care solutions
Cesar Lipener
ADVANCES IN THERAPY (2009)
Allergy to ophthalmic preservatives
Jison Hong et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Ocular preservatives: associated risks and newer options
Indu Pal Kaur et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2009)
Clinical Evaluation of Long-Term Users of Two Contact Lens Care Preservative Systems
Graeme Young et al.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2009)
Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells
Seth P. Epstein et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Protecting the Ocular Surface and Improving the Quality of Life of Dry Eye Patients: A Study of the Efficacy of an HP-Guar Containing Ocular Lubricant in a Population of Dry Eye Patients
Maurizio Rolando et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Evaluation of Biomarkers of Inflammation in Response to Benzalkonium Chloride on Corneal and Conjunctival Epithelial Cells
Seth P. Epstein et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Multiple Endpoint Analysis of the 3D-Reconstituted Corneal Epithelium after Treatment with Benzalkonium Chloride: Early Detection of Toxic Damage
Aude Pauly et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Preservatives in topical ophthalmic medications: historical and clinical perspectives
P. David Freeman et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2009)
Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2008)
Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis
Thomas Hamacher et al.
ACTA OPHTHALMOLOGICA (2008)
Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Malik Y. Kahook et al.
ADVANCES IN THERAPY (2008)
Corneal Staining Reductions Observed after Treatment with Systane® Lubricant Eye Drops
Mike T. Christensen
ADVANCES IN THERAPY (2008)
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea
Soumyajit Majumdar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Duration of IOP reduction with travoprost BAK-free solution
Ronald L. Gross et al.
JOURNAL OF GLAUCOMA (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Doctor-patient communication, health-related beliefs, and adherence in glaucoma
David S. Friedman et al.
OPHTHALMOLOGY (2008)
In vivo corneal epithelial permeability following treatment with prostaglandin analoges with or without benzalkonium chloride
Bernard McCarey et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
The comparative clinical performance of a new polyhexamethylene biguanide- vs a polyquad-based contact lens care regime with two silicone hydrogel contact lenses
Jacinto Santodomingo-Rubido
OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2007)
The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Richard W. Yee
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Travoprost 0.004% with and without benzalkonium chloride: A comparison of safety and efficacy
Richard A. Lewis et al.
JOURNAL OF GLAUCOMA (2007)
Travoprost Z ophthalmic solution with sofZia: clinical safety and efficacy
Malik Y. d Kahook
EXPERT REVIEW OF OPHTHALMOLOGY (2007)
Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system
Ruth A. Rosenthal et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Corneal toxicity from topical ocular and systemic medications
F. W. Fraunfelder
CORNEA (2006)
Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride
Jess T. Whitson et al.
ADVANCES IN THERAPY (2006)
Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution
Douglas C. Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1
Jess T. Whitson et al.
OPHTHALMOLOGY (2006)
Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1:: An experimental study
Antoine Labbe et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system
Richard W. Yee et al.
ADVANCES IN THERAPY (2006)
Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients
DL Easty et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Effect of benzalkonium chloride on transscleral drug delivery
K Okabe et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population
I Hartstein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro
SH Cha et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Identification of genes involved in the susceptibility of Serratia marcescens to polyquaternium-1
CE Codling et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Corneal and conjunctival changes caused by commonly used glaucoma medications
RJ Noecker et al.
CORNEA (2004)
Aspects of the antimicrobial mechanisms of action of a polyquaternium and an amidoamine
CE Codling et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Eyedrop-induced allergy: Clinical evaluation and diagnostic protocol
MT Ventura et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2003)
Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen
L Jones et al.
OPTOMETRY AND VISION SCIENCE (2002)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
LJ Katz
JOURNAL OF GLAUCOMA (2002)
Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation
D Monti et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery
H Eleftheriadis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Commercially available ocular hypotensive products: Preservative concentration, stability, storage, and in-life utilization
GD Novack et al.
JOURNAL OF GLAUCOMA (2001)
Effects of common ophthalmic preservatives on ocular health
R Noecker
ADVANCES IN THERAPY (2001)
分享论文
